NCT04402788 | NRG-LU007 | NRG
Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR trial
NCT06616584 | S1800E | SWOG
A Randomized Phase II/III Study of Docetaxel and Ramucirumab with or Without Cemiplimab (REGN2810) for Participants Previously Treated with Platinum-Based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
6498635 | S2414 | SWOG
A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT)
| FRNM-009 | DRUG CO
Blood Specimen Collection Study for Development of a Blood Test for Early Detection of Lung Cancer
NCT04267848 | A081801 | ALLIANCE
Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO
NCT03851445 | LungMAP | SWOG
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
NCT05624996 | NRG-LU008 | NRG
Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
NCT06632327 | CTIU2317-A082304-S2402 | ALLIANCE
PERIOPERATIVE VERSUS ADJUVANT SYSTEMIC THERAPY IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER –PROSPECT LUNG
NCT06096844 | EA5221 | ECOG-ACRIN
A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study